AndroFeme® Cream vs Intrinsa® Patch
There are not many options available for women suffering from low testosterone or low libido. Topical gels and creams are recommended but many times a woman will need to take a male testosterone product and adjust the dosage to be suitable, or a compounded formula will need to be purchased from a compounding pharmacy. AndroFeme cream is one of the only female low testosterone products on the market.
There used to be patch called Intrinsa®
but this has now been discontinued. Hopefully a new patch will come back on the market soon.
The Intrinsa testosterone patch (made by Procter & Gamble) was developed specifically to treat Female Sexual Dysfunction (FSD). Wearing the slow releasing testosterone patch is considered a convenient and attractive application for women. However, the FDA rejected it and the EU have now discontinued supporting and prescribing it.
The patch dosage was 300 µg/24 hours, an amount suitable for women and much lower than the male version patches. It was relatively small in size, about the size of an egg, and it was flesh coloured so it camouflaged into the skin quite well. The patches were placed discreetly below the naval and needed to be replaced 2 times a week.
The dismissal of this patch leaves women with only one credible form of testosterone therapy. A cream called AndroFeme®. It is made by a Pharmaceutical company in Australia and it remains the only licensed testosterone product for women with low testosterone, available for worldwide shipping.
A tube of AndroFeme®
testosterone cream contains 50 doses of 10 mg each. When starting to use testosterone therapy it is recommended that women start on a lower, ideally 0.5 ml (5 mg) per day. After the initial adjustment, it can be adjusted to a full dose. A tube of AndroFeme® costs $122 including free shipping and it can last anywhere from 50-100 days (depending on the dosage) so it is highly cost-effective.
Read more about testosterone therapy for women
with low testosterone and low libido.